English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51946158    Online Users :  958
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 560371-560380 of 2348419  (234842 Page(s) Totally)
<< < 56033 56034 56035 56036 56037 56038 56039 56040 56041 56042 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2018-09-10T18:04:09Z Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH
臺大學術典藏 2017 Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:05Z Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:08Z Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-09-08T08:16:43Z Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; PAN-CHYR YANG; Shih, Jin-Yuan
國立臺灣大學 2008 Lung Adenocarcinoma with Good Response to Erlotinib after Gefitinib Treatment Failure and Acquired T790m Mutation 吳尚俊; 施金元; 余忠仁; 楊泮池; WU, SHANG-GIN; SHIH, JIN-YUAN; YU, CHONG-JEN; YANG, PAN-CHYR
臺大學術典藏 2018-09-10T06:47:49Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation Wu, S.-G. and Shih, J.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T08:25:32Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation SHANG-GIN WU; Shih J.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-12-02T02:34:38Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation Wu S.-G.;Shih J.-Y.;Yu C.-J.;Pan-Chyr Yang; Wu S.-G.; Shih J.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2022-06-27T07:06:27Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation Wu S.-G.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C.

Showing items 560371-560380 of 2348419  (234842 Page(s) Totally)
<< < 56033 56034 56035 56036 56037 56038 56039 56040 56041 56042 > >>
View [10|25|50] records per page